Beigene LtdBeigene Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The webpage is a free ESG report covering Beigene Ltd. This report of Beigene Ltd is assembled by All Street Sevva using proprietary artificial intelligence. Other corporations in the scoring industry group for Beigene Ltd are displayedin the table.

Beigene Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.0; made up of an environmental score of 6.9, social score of 4.6 and governance score of 8.0.

SDG Transparency Score for Beigene Ltd 
Low
0 - 3
Medium
4 - 6

7.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Beigene Ltd 
6.9

Environmental

4.6

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
326Xencor Inc
7.1
High
326iCo Therapeutics Inc
7.1
High
355Beigene Ltd
7.0
High
355Agile Therapeutics Inc
7.0
High
355Antisense Therapeutics Ltd
7.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Beigene Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Beigene Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Beigene Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Beigene Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Beigene Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Beigene Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Beigene Ltd offer flexible work?

LockedSign up for free to unlock

Does Beigene Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Beigene Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Beigene Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Beigene Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Beigene Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Beigene Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Beigene Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Beigene Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Beigene Ltd disclose water use targets?

LockedSign up for free to unlock

Does Beigene Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Beigene Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Beigene Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Beigene Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Beigene Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Beigene Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Beigene Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Beigene Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Beigene Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Beigene Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Beigene Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Beigene Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Beigene Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Beigene Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Beigene Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Beigene Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Beigene Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Beigene Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Beigene Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Beigene Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Beigene Ltd
These potential risks are based on the size, segment and geographies of the company.

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Sorry!

Failed to process!